Skip to content

Bone Metabolism Adjacent to Hip Prosthetic Surfaces. A Clinical F-PET/CT Study

Bone Metabolism Adjacent to Hip Prosthetic Surfaces. A Randomized Clinical F-PET/CT Study.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02320682
Acronym
Fp-III
Enrollment
32
Registered
2014-12-19
Start date
2014-12-31
Completion date
2021-12-31
Last updated
2018-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Osteo Arthritis

Brief summary

What is the intensity of F-PET uptake adjacent to four analyzed hip endoprosthetic components and in healthy femur and acetabulum, 1, 4 and 9 months after surgery?

Detailed description

A clinical study of 32 patients, age 50-69 years, healthy unless osteoarthritis in one hip, randomized in two groups (16 each) plus a reference group of same 32 patient´s contralateral healthy hip. Intervention will be surgery with a total hip arthroplasty. The four studied endoprosthetic components are: * Cemented Exeter stem (Stryker Warsaw, USA) with a ceramic 32 mm head and Palacose cement with gentamycin, applied with 3:rd generation cementation technique. * Uncemented Lubinus SP-CL stem (Waldemar Link, Hamburg, Germany) with a ceramic 32 mm head. * Uncemented Delta PF cup (Limacorporate spa, Udine, Italy). * Uncemented fibrous metal Delta TT cup (Limacorporate spa, Udine, Italy). Both cups will have cross linked Ultra-high-molecular-weight polyethylene (UHWMP). Clinical score, radiography and uptake of Fluoride tracer will be analyzed.

Interventions

DEVICESurgery for Total Hip Arthroplasty (THA)

THA surgery where four prosthetic components will randomly be inserted. Randomly an Exeter or SP-CL femur component will be combined with randomly a Delta TT or Delta PF acetabular component.

Sponsors

gosta ullmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

\- patients diagnosed to have unilateral hip osteo arthritis verified by radiography (Charnley group A) aimed for THA at Gävle hospital and accepting to participate in the study.

Exclusion criteria

* any systemic disease (other than osteo arthritis) or medication affecting skeleton methabolism

Design outcomes

Primary

MeasureTime frameDescription
ACETABULUM: to analyze difference in SUV of all 9 ROI's analyzed together between the two study groups (PF and TT), and to analyze SUV of all 9 ROI's analyzed together between each acetabulum prosthetic component study group and the reference group1 months after surgeryThere are two study groups for acetabulum: two models of uncemented acetabular prosthetic components. There is also an acetabular reference group.
FEMUR: to analyze difference in SUV of the 4 upper ROI's (No 1, 7, 8 and 13) analyzed together between the two study groups AND: to analyze SUV of the 4 upper ROI's analyzed together between each femur study group and the reference group1 months after surgeryThere are two study groups for femur: cemented and uncemented femur prosthetic components. There is also a femur reference group.

Secondary

MeasureTime frame
FEMUR: to analyze difference in SUV for each individual ROI between the cemented study group and the reference group. To analyze difference in SUV for each individual ROI between the uncemented study group and the reference group.1, 4 and 9 months aftyer surgery
FEMUR:to analyze difference in SUV for each individual ROI between the 3 time points for the cemented group. To analyze difference in SUV for each individual ROI between the 3 time points for the uncemented group.1, 4 and 9 months aftyer surgery
FEMUR:to analyze difference in SUV for the 4 upper ROI's (No 1, 7, 8 and 13) analyzed together between the 2 study groups4 and 9 months aftyer surgery
FEMUR:to analyze difference in SUV for the 4 upper ROI's analyzed together between each study group and the reference group4 and 9 months aftyer surgery
ACETABULUM: to analyze difference in SUV for each individual ROI between the two study groups. To analyze difference in SUV for each individual ROI between each of the two study groups and the reference group.1, 4 and 9 months aftyer surgery
ACETABULUM: to analyze difference in SUV for each individual ROI for the Delta PF study group between the 3 time points. To analyze difference in SUV for each individual ROI for the Delta TT study group between the 3 time points.1, 4 and 9 months aftyer surgery
ACETABULUM: to analyze difference in SUV of all 9 ROI's analyzed together between the two acetabular study groups4 and 9 months aftyer surgery
ACETABULUM: to analyze SUV of all 9 ROI's analyzed together between each acetabulum study group and the reference group4 and 9 months
ACETABULUM: to analyze difference in SUV for each individual ROI between the 2 study groups1, 4 and 9 months aftyer surgery
FEMUR:to analyze difference in SUV for each individual ROI inbetween the cemented and uncemented femur group1, 4 and 9 months aftyer surgery

Other

MeasureTime frameDescription
To analyze radiographic difference for each of the four study groups between direct postoperativ and 9 months postoperative radiographs.Direct postoperative (1-3 days) and 9 months
To analyze clinical score for the four study groupspreoperatively and 9 months postoperatively.Merle d Merle d´Aubignè and Postel score

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026